Page last updated: 2024-10-21

hydroxyindoleacetic acid and Channelopathies

hydroxyindoleacetic acid has been researched along with Channelopathies in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Channelopathies: A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horvath, GA1
Demos, M1
Shyr, C1
Matthews, A1
Zhang, L1
Race, S1
Stockler-Ipsiroglu, S1
Van Allen, MI1
Mancarci, O1
Toker, L1
Pavlidis, P1
Ross, CJ1
Wasserman, WW1
Trump, N1
Heales, S1
Pope, S1
Cross, JH1
van Karnebeek, CD1

Other Studies

1 other study available for hydroxyindoleacetic acid and Channelopathies

ArticleYear
Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
    Molecular genetics and metabolism, 2016, Volume: 117, Issue:1

    Topics: Autistic Disorder; Channelopathies; Child; Drug Resistant Epilepsy; Epilepsy; Exome; Female; Homovan

2016